Announcements Trials
Browse Landscape

Phase

Phase NA 6

Status

Completed 37Recruiting 18Active not recruiting 6Not yet recruiting 4Enrolling by invitation 3Unknown 2Terminated 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 2Tumor-Agnostic 1Thoracic 1Gynecologic 1Breast 1

Conditions

Hematologic Neoplasms 2Uterine Cervical Neoplasms 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Patient Navigation × Clear all
NCT04960787 2026-05-14

CREDIT

SWOG Cancer Research Network

Phase NA Active not recruiting
331 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT06950008 2026-05-11

A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Active not recruiting
75 enrolled
Breast

Breast Neoplasms

NCT06383988 2026-04-13

CONNECT

Wake Forest University Health Sciences

Phase NA Active not recruiting
216 enrolled
Thoracic

Lung Neoplasms

NCT04234646 2025-12-22

Patient Navigation 2.0

Northwestern University

Phase NA Active not recruiting
600 enrolled
Tumor-Agnostic

Neoplasms

NCT04630431 2025-12-17

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Mayo Clinic

Phase NA Active not recruiting
590 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06577220 2025-10-14

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Baylor College of Medicine

Phase NA Active not recruiting
111 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡